Montreal
-
Novo Nordisk Aims to Succeed Where Sanofi Faltered Drugging a Weight-Loss Target
Novo Nordisk isn’t putting all of its weight loss drug hopes in the same basket. Its acquisition of Inversago Pharma for up to $1 billion will bring a biotech whose lead drug candidate has early clinical trial data showing significant weight loss.
-
Artificial Intelligence, BioPharma
AI-driven Congruence Therapeutics gets $50M to stabilize misfolded proteins
Biotech startup Congruence Therapeutics is developing novel drugs that treat disease by stabilizing misfolded proteins. Key to the company’s approach is a computational platform that discovers and designs these small molecule stabilizers.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Ventus Therapeutics tacks on $100M to take on ‘undruggable’ disease targets
RA Capital led Ventus Therapeutics’ Series B financing, which the startup will use to develop its pipeline of medicines for “undruggable” disease targets. CEO Marcelo Bigal said the cash also gives Ventus the flexibility to consider an IPO.
-
Valeant looking for new CEO as Pearson steps down – desperation calls for change?
Today it was announced that Valeant CEO Mike Pearson is officially walking away from his position with the pharmaceutical company, though he will stay on board until a replacement is established.
-
The space adventures of wearable tech
The Canadian Space Agency has inked a deal with med tech company Hexoskin to develop wearables with an eye to supporting remote monitoring of their astronauts’ vital signs in space.
-
New kiddie wearable: ‘personal nanny’ or mind control for toddlers?
Invented by two outdoors enthusiasts-turned-dads, Hoko, which comes with an activities book, is supposed to make sure children are comfortable so parents can plan family adventures without being interrupted by crying or tantrums. Our warped minds had other thoughts.
-
Devices & Diagnostics, Health IT, Startups
Jintronix raising up to $5M to scale rehabilitation software business
Digital health company Jintronix is in the midst of fundraising for a Series A round […]
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.